Report overview
This report aims to provide a comprehensive presentation of the global market for Next-Generation Breast Cancer Diagnostic and Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Breast Cancer Diagnostic and Screening. This report contains market size and forecasts of Next-Generation Breast Cancer Diagnostic and Screening in global, including the following market information:
Global Next-Generation Breast Cancer Diagnostic and Screening Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Next-Generation Breast Cancer Diagnostic and Screening market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Real-Time PCR (q-PCR) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Next-Generation Breast Cancer Diagnostic and Screening include Abbott Laboratories, Agendia, Agilent Technologies, Ambry Genetics, Biocept, Biotheranostics, Centogene, Danaher Corporation and EXACT Sciences Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Next-Generation Breast Cancer Diagnostic and Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next-Generation Breast Cancer Diagnostic and Screening Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, by Type, 2022 (%)
Real-Time PCR (q-PCR)
Immunohistochemistry (IHC)
Next-Generation Sequencing (NGS)
Fluorescent In-Situ Hybridization (FISH)
Global Next-Generation Breast Cancer Diagnostic and Screening Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, by Application, 2022 (%)
Hospital-associated Labs
Cancer Research Institutes
Diagnostic Centers
Global Next-Generation Breast Cancer Diagnostic and Screening Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Next-Generation Breast Cancer Diagnostic and Screening Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next-Generation Breast Cancer Diagnostic and Screening revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Next-Generation Breast Cancer Diagnostic and Screening revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Agendia
Agilent Technologies
Ambry Genetics
Biocept
Biotheranostics
Centogene
Danaher Corporation
EXACT Sciences Corporation
Roche Holding AG
Fulgent Genetics
Illumina
Invitae
Lucence Diagnostics Pte Ltd
Myriad Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next-Generation Breast Cancer Diagnostic and Screening, market overview.
Chapter 2: Global Next-Generation Breast Cancer Diagnostic and Screening market size in revenue.
Chapter 3: Detailed analysis of Next-Generation Breast Cancer Diagnostic and Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next-Generation Breast Cancer Diagnostic and Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
